ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED
Clinical trials for ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat leukemia: experimental drug cocktails tested in younger patients
Disease control Recruiting nowThis study is for adults aged 59 and younger with a high-risk form of acute myeloid leukemia (AML) that is harder to treat. It compares the standard chemotherapy with several newer drug combinations to see which works better at shrinking the cancer. About 335 people will take par…
Matched conditions: ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New screening tool aims to speed up matching cancer patients to the right clinical trials
Knowledge-focused Recruiting nowThis study is for adults with newly diagnosed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who have not yet received treatment. Researchers will test blood and bone marrow samples for specific biomarkers to see if participants can join a treatment trial that tar…
Matched conditions: ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC